MiRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease

World Journal of Gastroenterology

Volumn 21, Issue 2, 2015, Pages 511-516

  Xu, Qian ^a   Li, Ying ^a   Shang, Yong Fang ^a   Wang, Hui Ling ^a   Yao, Min Xiu ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Insulin resistance; MiRNA 103; Nonalcoholic fatty liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; INSULIN; MICRORNA; MICRORNA 103; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; MIRN103 MICRORNA, HUMAN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; DIET RESTRICTION; GENETICS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; UPREGULATION;

ADULT; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; RISK FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 84920950260     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i2.511     Document Type: Article

References (26)

1. Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol 2013; 28 Suppl 1: 11-17 [PMID: 23855290 DOI: 10.1111/jgh.12036]
2. Novakovic T, Mekic M, Smilic L, Smilic T, Inić-Kostic B, Jovicevic L, Mirkovic Z, Milinic S. Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods. Med Arch 2014; 68: 22-26 [PMID: 24783906]
3. Wang F, Zheng Z, Guo J, Ding X. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 2010; 119: 586-593 [PMID: 20801493 DOI: 10.1016/j.ygyno.2010.07.021]
4. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251: 499-505 [PMID: 20134314 DOI: 10.1097/SLA.0b013e3181cc939f]
5. Waters PS, McDermott AM, Wall D, Heneghan HM, Miller N, Newell J, Kerin MJ, Dwyer RM. Relationship between circulating and tissue microRNAs in a murine model of breast cancer. PLoS One 2012; 7: e50459 [PMID: 23226290 DOI: 10.1371/journal.pone.0050459]
6. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, Liu S. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 2010; 5: e13735 [PMID: 21060830 DOI: 10.1371/journal.pone.0013735]
7. Cookson VJ, Bentley MA, Hogan BV, Horgan K, Hayward BE, Hazelwood LD, Hughes TA. Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours. Cell Oncol (Dordr) 2012; 35: 301-308 [PMID: 22821209 DOI: 10.1007/s13 402-012-0089-1]
8. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011; 474: 649-653 [PMID: 21654750 DOI: 10.1038/nature10112]
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419 [PMID: 3899825]
10. Takaki A, Kawai D, Yamamoto K. Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int J Mol Sci 2014; 15: 7352-7379 [PMID: 24786095 DOI: 10.3390/ijms15057352]
11. Park JS, Seo JH, Youn HS. Gut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease. Pediatr Gastroenterol Hepatol Nutr 2013; 16: 22-27 [PMID: 24010102]
12. França LM, Freitas LN, Chagas VT, Coɥlho CF, Barroso WA, Costa GC, Silva LA, Debbas V, Laurindo FR, Paes AM. Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation. Biochem Biophys Res Commun 2014; 443: 725-730 [PMID: 24333444 DOI: 10.1016/ j.bbrc.2013.12.042]
13. Lou DJ, Zhu QQ, Si XW, Guan LL, You QY, Yu ZM, Zhang AZ, Li D. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and nonalcoholic fatty liver disease. J Diabetes Complications 2014; 28: 711-714 [PMID: 24927647 DOI: 10.1016/j.jdiacomp.2014.04.008]
14. Bruno Ade S, Rodrigues MH, Alvares MC, Nahas-Neto J, Nahas EA. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women. Climacteric 2014; 17: 465-471 [PMID: 24517420]
15. Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoidinduced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am 2014; 43: 75-102 [PMID: 24582093 DOI: 10.1016/j.ecl.2013.10.005]
16. Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee CH, Manning BD. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 2011; 14: 21-32 [PMID: 21723501 DOI: 10.1016/j.cmet.2011.06.002]
17. Miyaaki H, Ichikawa T, Kamo Y, Taura N, Honda T, Shibata H, Milazzo M, Fornari F, Gramantieri L, Bolondi L, Nakao K. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. Liver Int 2014; 34: e302-e307 [PMID: 24313922 DOI: 10.1111/liv.12429]
18. Yamada H, Suzuki K, Ichino N, Ando Y, Sawada A, Osakabe K, Sugimoto K, Ohashi K, Teradaira R, Inoue T, Hamajima N, Hashimoto S. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta 2013; 424: 99-103 [PMID: 23727030 DOI: 10.1016/j.cca.2013.05.021]
19. Zhang Y, Cheng X, Lu Z, Wang J, Chen H, Fan W, Gao X, Lu D. Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease. Diabetes Res Clin Pract 2013; 99: 327-334 [PMID: 23287814 DOI: 10.1016/ j.diabres.2012.11.025]
20. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One 2011; 6: e23937 [PMID: 21886843 DOI: 10.1371/journal.pone.0023937]
21. Hoekstra M, van der Sluis RJ, Kuiper J, Van Berkel TJ. Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. J Nutr Biochem 2012; 23: 622-628 [PMID: 21764575 DOI: 10.1016/j.jnutbio.2011.03.005]
22. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 2008; 94: 206-218 [PMID: 18037457]
23. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946 [PMID: 11479627]
24. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009; 58: 1050-1057 [PMID: 19188425 DOI: 10.2337/db08-1299]
25. Abangah G, Yousefi A, Asadollahi R, Veisani Y, Rahimifar P, Alizadeh S. Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease. Iran Red Crescent Med J 2014; 16: e12669 [PMID: 24719704 DOI: 10.5812/ircmj.12669]
26. Jiang Y, Zeng J, Chen B. Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver. J Gastroenterol Hepatol 2014; 29: 1508-1514 [PMID: 24628002 DOI: 10.1111/jgh.12580]